Principal Development Engineer

Arbetsbeskrivning

Who we are
Olink Proteomics is a rapidly growing life science company committed to advancing the understanding of human diseases through proteomics. We are dedicated to innovation, quality, rigor and transparency, providing outstanding solutions and support for human protein biomarker discovery.
The vital role of proteins in understanding human biology has been recognized for many decades, but technological limitations severely restricted the comprehensive investigation of the huge number of proteins that could be important in different biological processes and diseases. With Olink, scientists can now simultaneously measure thousands of human proteins using just a few µL of blood sample, with highly specific, thoroughly validated assays that cover a very wide dynamic range (fg/mL to µg/mL).
In a few years, Olink has grown rapidly from a small, Sweden-based company offering assays for a few hundred proteins, to a NASDAQ-listed organization with a strong global presence, a broad portfolio of flexible protein biomarker solutions and library of high quality, thoroughly validated assays that covers ~5400 proteins.
For more information about Olink, please visit www.olink.com
Position Description
Olink Proteomics continues to grow, and we are now seeking a highly motivated and experienced Principal Development Engineer to join our R&D team with a focus on technical development of our highplex products. In this role you will play a key role both in research projects as well as in product development projects. The projects may include development of molecular methods, immune assays, automation, scale-up and trouble shooting. The role is based in our Uppsala headquarter.
Primary responsibilities
Drive innovation projects within the area of the product portfolio
Utilize your expertise in molecular biology to improve sensitivity, specificity, and robustness
Lead and design laboratory experiments to validate and optimize protocols and technical solutions
Analyze large data sets and draw conclusions
Mentor and provide scientific guidance to more junior members of the team
Documenting results in technical reports and presenting results at conferences or meetings
Collaborate cross functionally to support product development and investigations
Provide scientific expertise and direction for research and development projects

Qualifications/skills
Ph.D. from the LifeScience area or RnD experience from the industry that the employer deems to be equal
A minimum of 5 years of experience in product development
Significant experience from molecular techniques such as NGS, qPCR and PCR
Experience of working in projects
Strong analytical and problem-solving skills
Experience with multiplex assay development is highly desirable
Excellent teamwork and communication skills
Ability to work in a fast-paced, collaborative environment
Well documented experience from lab work
Knowledge in data analysis and technical problem solving

To succeed in this role we believe that you are committed, driven and solution oriented. You are a team player that can work with many personalities. You are thorough and analytical. It is also important that you are positive and can adjust to changed circumstances.
If you are a driven scientist with a passion for developing innovative protein assays and want to be part of a team at the forefront of biotechnology, we encourage you to apply. Please submit your resume and a cover letter detailing your relevant experience and why you are the ideal candidate for this position. The last day for applying is on the 18th of December 2023 but please submit your application as soon as possible.

Sammanfattning

  • Arbetsplats: Olink Proteomics AB
  • 1 plats
  • Tills vidare
  • Heltid
  • Fast månads- vecko- eller timlön
  • Publicerat: 4 december 2023
  • Ansök senast: 16 december 2023

Besöksadress

DAG HAMMARSKJÖLDS VÄG 52 B
None

Postadress

None
UPPSALA, 75237

Liknande jobb


QA/RA-ingenjör

QA/RA-ingenjör

2 maj 2024

BioProcess Engineer

23 april 2024

BioProcess Operator

23 april 2024